Home Cart Sign in  
Chemical Structure| 5798-94-7 Chemical Structure| 5798-94-7

Structure of 5798-94-7

Chemical Structure| 5798-94-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 5798-94-7 ]

CAS No. :5798-94-7
Formula : C7H6BrNO3
M.W : 232.03
SMILES Code : O=C(NO)C1=CC(Br)=CC=C1O
MDL No. :MFCD00493566

Safety of [ 5798-94-7 ]

Application In Synthesis of [ 5798-94-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 5798-94-7 ]

[ 5798-94-7 ] Synthesis Path-Upstream   1~2

  • 1
  • [ 5798-94-7 ]
  • [ 65685-50-9 ]
YieldReaction ConditionsOperation in experiment
88%
Stage #1: With thionyl chloride In tetrahydrofuran at 10 - 20℃; for 2 h;
Stage #2: With triethylamine In 1,4-dioxane at 0 - 20℃;
To a solution of δ-bromosalicylcarbohydroxamic acid F2 (21.6 g) in tetrahydrofuran (60 ml) was added thionyl chloride (10 ml) dropwise with stirring at 10-200C. After being stirred for 2 h at the same temperature, the reaction mixture was evaporated under reduced pressure and the residue was dissolved in dioxane (60 ml) and cooled to 0-50C Tπethylamine (38 ml) was added to the reaction mixture and stirred at room temperature for 1 hour. The solvent was evaporated under reduced pressure and ice water (30OmL) was added to the residue. The mixture was adjusted to pH 2 with concentrated hydrochloric acid and the crystals precipitated were filtered and washed with water. Compound F3 (17.5 g, 88percent) was obtained as colorless needle crystals by recrystallization from ethyl acetate
3.71 g With 1,1'-carbonyldiimidazole In tetrahydrofuran for 3 h; Reflux Step 2:
5-bromo-N,2-dihydroxybenzamide (4.12 g, 17.76 mmol) was suspended in 100 mL THF. Carbonyldiimidazole (5.76 g, 35.5 mmol) was added and the mixture was heated under reflux for three hours.
The solvent was evaporated under vacuum, 100 mL water was added and the solution was acidified to pH 1 with 1N HCl under rapid stirring.
The formed precipitate was filtered, washed with water and dried, giving 5-bromobenzo[d]isoxazol-3-ol (3.71 g, 17.3 mmol) as off-white solid.
References: [1] Patent: WO2011/20615, 2011, A1, . Location in patent: Page/Page column 75; 76.
[2] Journal of Medicinal Chemistry, 2008, vol. 51, # 12, p. 3357 - 3359.
[3] Patent: US2015/175560, 2015, A1, . Location in patent: Paragraph 0468; 0470.
  • 2
  • [ 5798-94-7 ]
  • [ 65685-50-9 ]
References: [1] Australian Journal of Chemistry, 1977, vol. 30, p. 1847 - 1850.
 

Historical Records